These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32695966)

  • 1. Should we use liver grafts repeatedly refused by other transplant teams?
    Winter A; Landais P; Azoulay D; Disabato M; Compagnon P; Antoine C; Jacquelinet C; Daurès JP; Féray C
    JHEP Rep; 2020 Aug; 2(4):100118. PubMed ID: 32695966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matching Graft Quality to Recipient's Disease Severity Based on the Survival Benefit in Liver Transplantation.
    Winter A; Féray C; Antoine C; Azoulay D; Daurès JP; Landais P
    Sci Rep; 2020 Mar; 10(1):4111. PubMed ID: 32139780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival advantage for patients accepting the offer of a circulatory death liver transplant.
    Taylor R; Allen E; Richards JA; Goh MA; Neuberger J; Collett D; Pettigrew GJ;
    J Hepatol; 2019 May; 70(5):855-865. PubMed ID: 30639505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allocation of liver grafts worldwide - Is there a best system?
    Tschuor C; Ferrarese A; Kuemmerli C; Dutkowski P; Burra P; Clavien PA;
    J Hepatol; 2019 Oct; 71(4):707-718. PubMed ID: 31199941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.
    Angelico M; Cillo U; Fagiuoli S; Gasbarrini A; Gavrila C; Marianelli T; Costa AN; Nardi A; Strazzabosco M; Burra P; Agnes S; Baccarani U; Calise F; Colledan M; Cuomo O; De Carlis L; Donataccio M; Ettorre GM; Gerunda GE; Gridelli B; Lupo L; Mazzaferro V; Pinna A; Risaliti A; Salizzoni M; Tisone G; Valente U; Rossi G; Rossi M; Zamboni F;
    Dig Liver Dis; 2011 Feb; 43(2):155-64. PubMed ID: 21185796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation.
    Schlegel A; Kalisvaart M; Scalera I; Laing RW; Mergental H; Mirza DF; Perera T; Isaac J; Dutkowski P; Muiesan P
    J Hepatol; 2018 Mar; 68(3):456-464. PubMed ID: 29155020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue allocation for liver transplantation within Eurotransplant: the Heidelberg experience.
    Schemmer P; Nickkholgh A; Gerling T; Weitz J; Büchler MW; Schmidt J
    Clin Transplant; 2009 Dec; 23 Suppl 21():42-8. PubMed ID: 19930316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
    Trotter JF; Osgood MJ
    JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Transplantation with "Hors Tour" Allocated Versus Standard MELD Allocated Grafts: Single-Center Audit and Impact on the Liver Pool in France.
    Azoulay D; Disabato M; Gomez-Gavara C; Feray C; Salloum C; Ngonggang N; Winter A; Hentati H; Levesque E; Lim C; Compagnon P
    World J Surg; 2020 Mar; 44(3):912-924. PubMed ID: 31832704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
    Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
    Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of kidney grafts refused by one or more centers and subsequently transplanted at a single United Kingdom center.
    Farid S; Aldouri A; Fraser S; Al-Mukhtar A; Newstead C; Lewington A; Baker R; Menon K; Ahmad N
    Transplant Proc; 2009 Jun; 41(5):1541-6. PubMed ID: 19545675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of liver transplantation waiting list for decompensated cirrhosis in a Spanish tertiary hospital: differences between hepatitis C virus recipients and other etiologies.
    Ibáñez Samaniego L; Pérez Valderas M; Fernández Yunquera A; Rincón Rodríguez D; López Baena JA; Matilla Peña A; Catalina Rodríguez MV; Clemente Ricote G; Bañares Cañizares R; Salcedo Plaza M
    Transplant Proc; 2014 Nov; 46(9):3084-6. PubMed ID: 25420829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis.
    Vitale A; Saracino E; D'Amico FE; Grigoletto F; Burra P; Angeli P; Boccagni P; Brolese A; Zanus G; Neri D; Gringeri E; D'Amico F; Valmasoni M; Carraro A; Gambato M; Feltracco P; Romano A; Buggio M; D'Amico DF; Cillo U
    Transplant Proc; 2009 May; 41(4):1092-5. PubMed ID: 19460489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation.
    Goldaracena N; Gorgen A; Doyle A; Hansen BE; Tomiyama K; Zhang W; Ghanekar A; Lilly L; Cattral M; Galvin Z; Selzner M; Bhat M; Selzner N; McGilvray I; Greig PD; Grant DR; Sapisochin G
    J Hepatol; 2019 Apr; 70(4):666-673. PubMed ID: 30630009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics.
    Bhat M; Ghali P; Dupont B; Hilzenrat R; Tazari M; Roy A; Chaudhury P; Alvarez F; Carrier M; Bilodeau M
    J Hepatol; 2017 Feb; 66(2):374-381. PubMed ID: 27751840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Wait-List Mortality Between Cholangiocarcinoma and Hepatocellular Carcinoma Liver Transplant Candidates.
    Ziogas IA; Hickman LA; Matsuoka LK; Izzy M; Montenovo MI; Rega SA; Feurer ID; Alexopoulos SP
    Liver Transpl; 2020 Sep; 26(9):1112-1120. PubMed ID: 32475062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.